We use cookies

    We use cookies to improve your experience. See our Cookie Policy.

    safety

    Peptide Purity Explained: What 99% HPLC Actually Means

    Baltic BioLabs Research Team•February 10, 2025Updated •
    4 min read

    99% HPLC purity usually means that the assigned target peak accounts for 99% of the integrated detector signal under the reported method. It does not mean that 99% of the vial’s gross powder weight is peptide. Net peptide content, intact mass, sequence confirmation, residual solvents and microbial quality are separate measurements.

    This guide explains what a lot report can support, and what additional information is needed to prepare a reliable stock concentration.

    Schematic peptide HPLC chromatogram showing a main peak and smaller peaks
    Conceptual chromatogram, not a lot report. Peak-area purity is separate from net peptide content and sequence confirmation.
    View full-size illustration
    Research Use Only Statement:The products and information provided on this page are intended exclusively for in vitro laboratory research and educational purposes. They are strictly not for human consumption, diagnostic, or therapeutic use. Always adhere to your institution's safety protocols and local regulations when handling these compounds. The subsequent studies and findings referenced are drawn from third-party scientific literature for informational context only and do not constitute professional medical advice.

    Why Purity Matters

    Impurities can confound a bioassay, but purity and quantity answer different questions. A “10 mg, 80% HPLC purity” label does not, on its own, demonstrate 8 mg of target peptide. HPLC peak-area fraction is detector- and method-dependent; gross powder can also contain water, counterions, salts and residual solvents.

    To calculate a stock concentration, obtain a quantitative peptide-content or target-analyte assay with a stated basis. If 10 mg is verified gross mass and a validated assay establishes an 80% target mass fraction, 8 mg is a supported calculation. A peak-area purity percentage alone does not provide that gravimetric mass fraction.

    Analytical Methods

    Analytical methods provide complementary information. Their limits should be stated alongside their results.

    HPLC: Method-Specific Peak-Area Purity

    A chromatogram separates detectable components under the reported conditions. The reported area percentage depends on wavelength/detector, integration, chromatographic resolution and sample preparation. Co-eluting or poorly detected impurities may not be represented reliably. Request the method, trace, integration and target-peak assignment. A purity threshold should match the experiment’s specification; a universal sub-90% “poor quality” rule is not established by the cited sources.

    Intact Mass Is Not the Complete Sequence

    Mass spectrometry measures mass-to-charge ratios. A compatible deconvoluted intact mass supports the expected molecular composition, but it does not prove the full amino-acid sequence: different residue orders, some isobaric substitutions and stereochemical differences can share a mass. Sequence-resolving MS/MS, peptide mapping or other suitable structural methods may be needed. Salt, adduct, charge-state and modification assignments must be clear.

    Peptide Content and Amino Acid Analysis

    Quantitative amino-acid analysis can help determine peptide content after hydrolysis, with an appropriate validated method and accounting for method limitations. Composition is not residue order. A net-content result and an HPLC area-purity result should be reported separately, with units and the basis for any target-peptide quantity calculation.

    Interpreting Certificates of Analysis

    A useful Certificate of Analysis connects the received lot to the tested material. Check:

    • Name, sequence, modifications, salt/counterion and expected mass.
    • Matching lot/sample identifier and test date.
    • HPLC method, chromatogram, target-peak assignment and integration.
    • MS result with charge/adduct interpretation; sequence-level testing when the study requires it.
    • Quantitative net peptide content or target-analyte assay if concentration accuracy matters.
    • Residual-solvent, water/counterion, endotoxin or other results required for the particular model.
    • Laboratory identity, sampling information and storage/retest specification.

    Missing information is a limit on what the report supports. A short certificate without a chromatogram is not proof of fabrication, and an in-house report is not automatically false. Ask for the underlying data and verify the sample-to-lot link.

    Third-Party vs. In-House Testing

    Independent testing can reduce reliance on supplier assertions, but the laboratory is normally paid for its work. “Third party” does not mean no financial incentive, nor does it establish competent sampling or an appropriate method.

    Assess the laboratory’s method capability, traceable sample identifiers, report authenticity and disclosed scope. In-house and independent testing can be complementary. Neither label replaces the actual chromatogram, quantitative assay or structural evidence.

    Common Impurities and Contaminants

    Relevant quality attributes can include deletion/truncation products, chemical degradation, residual solvents, counterions and model-specific contaminants. TFA may be present as a counterion or residual processing reagent; it is not simply a generic impurity whose effect follows from HPLC area purity.

    HPLC does not establish endotoxin limits, sterility, absence of metals or total residual-solvent content unless the report includes a suitable assay for that attribute. Intentional copper coordination in GHK-Cu must also be distinguished from adventitious metal contamination.

    Practical Quality Verification Steps

    Before preparing a stock, match the lot and material to the protocol. Confirm whether the stated milligrams represent gross powder, net peptide content or quantitatively measured target compound. Use the verified amount and final volume, and record the calculation.

    Compare appearance and solubility with the supplied specification. Not all peptides are white or soluble in bacteriostatic water; GHK-Cu can be blue, and hydrophobic sequences can require other solvents. For critical measurements, consider independent testing that addresses the actual missing attribute rather than repeating only an intact-mass check.

    Conclusion

    A good lot report separates chromatographic purity, molecular identity and measured quantity. HPLC area purity describes the reported analytical trace; intact mass supports composition; a quantitative content assay supports concentration. Select tests and acceptance criteria for the model, and do not infer unmeasured quality attributes from a single percentage.

    Scientific References

    1. Merck/Sigma-Aldrich. Peptide Quick Tips: gross weight, net peptide content and purity - Primary source
    2. FDA. Biotechnology Inspection Guide: separate sequence, mass and purity characterization - Primary source
    3. PubChem. Copper peptide coordination-complex record - Primary source

    Related Research Peptides

    BPC-157
    Tissue Regeneration Research

    BPC-157

    Price
    From€31.99
    Live availability is confirmed before checkout
    Select Options
    Retatrutide
    Metabolic Research Compounds

    Retatrutide

    Price
    From€49.99
    Live availability is confirmed before checkout
    Select Options
    GHK-Cu
    Anti-Aging & Longevity

    GHK-Cu

    Price
    From€34.99
    Live availability is confirmed before checkout
    Select Options

    Continue Reading